Niedzwiecki D - Search Results

1

Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia.

Lin JT, Tong WP, Trippett TM, Niedzwiecki D, Tao Y, Tan C, Steinherz P, Schweitzer BI, Bertino JR. Lin JT, et al. Among authors: niedzwiecki d. Leuk Res. 1991;15(12):1191-6. doi: 10.1016/0145-2126(91)90189-z. Leuk Res. 1991. PMID: 1722550

2

Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines.

Li WW, Lin JT, Schweitzer BI, Tong WP, Niedzwiecki D, Bertino JR. Li WW, et al. Among authors: niedzwiecki d. Cancer Res. 1992 Jul 15;52(14):3908-13. Cancer Res. 1992. PMID: 1377601

3

Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.

Rusch VW, Niedzwiecki D, Tao Y, Menendez-Botet C, Dnistrian A, Kelsen D, Saltz L, Markman M. Rusch VW, et al. Among authors: niedzwiecki d. J Clin Oncol. 1992 Jun;10(6):1001-6. doi: 10.1200/JCO.1992.10.6.1001. J Clin Oncol. 1992. PMID: 1588364

4

Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.

Romanini A, Lin JT, Niedzwiecki D, Bunni M, Priest DG, Bertino JR. Romanini A, et al. Among authors: niedzwiecki d. Cancer Res. 1991 Feb 1;51(3):789-93. Cancer Res. 1991. PMID: 1988119

5

Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency.

Motzer RJ, Niedzwiecki D, Isaacs M, Menendez-Botet C, Tong WP, Flombaum C, Scher HI, Bosl GJ. Motzer RJ, et al. Among authors: niedzwiecki d. Cancer Chemother Pharmacol. 1990;27(3):234-8. doi: 10.1007/BF00685719. Cancer Chemother Pharmacol. 1990. PMID: 2176133

6

Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.

Göker E, Lin JT, Trippett T, Elisseyeff Y, Tong WP, Niedzwiecki D, Tan C, Steinherz P, Schweitzer BI, Bertino JR. Göker E, et al. Among authors: niedzwiecki d. Leukemia. 1993 Jul;7(7):1000-4. Leukemia. 1993. PMID: 7686600

7

Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor.

Saltz L, Sirott M, Young C, Tong W, Niedzwiecki D, Tzy-Jyun Y, Tao Y, Trochanowski B, Wright P, Barbosa K, et al. Saltz L, et al. Among authors: niedzwiecki d. J Natl Cancer Inst. 1993 Sep 15;85(18):1499-507. doi: 10.1093/jnci/85.18.1499. J Natl Cancer Inst. 1993. PMID: 7689654 Clinical Trial.

8

Pain and depression in patients with newly diagnosed pancreas cancer.

Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, Banks W, Brennan MF, Foley KM. Kelsen DP, et al. Among authors: niedzwiecki d. J Clin Oncol. 1995 Mar;13(3):748-55. doi: 10.1200/JCO.1995.13.3.748. J Clin Oncol. 1995. PMID: 7884435

9

Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.

Saltz L, Trochanowski B, Buckley M, Heffernan B, Niedzwiecki D, Tao Y, Kelsen D. Saltz L, et al. Among authors: niedzwiecki d. Cancer. 1993 Jul 1;72(1):244-8. doi: 10.1002/1097-0142(19930701)72:1<244::aid-cncr2820720143>3.0.co;2-q. Cancer. 1993. PMID: 8389666 Clinical Trial.

10

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.

Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, Niedzwiecki D, Botet J, Budd A. Kemeny N, et al. Among authors: niedzwiecki d. J Clin Oncol. 1993 Feb;11(2):330-5. doi: 10.1200/JCO.1993.11.2.330. J Clin Oncol. 1993. PMID: 8426211 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters